Advertisement


Dafna Bar-Sagi, PhD, on COVID-19: How Cancer Researchers Can Help Address the Challenges

AACR Virtual Meeting: COVID-19 and Cancer

Advertisement

Dafna Bar-Sagi, PhD, of New York University Langone Medical Center, summarizes a panel discussion she moderated on skills the cancer research community brings to bear on the coronavirus pandemic, how the influx of funding will affect future priorities, and ways to capitalize on the surge of interdisciplinary efforts to address medical issues.

The panel was composed of:

Ann D. Barker, Chief Strategy Officer at the Ellison Institute of University of Southern California.  Previously, Ann served as the Principal Deputy Director of the National Cancer Institute for strategic scientific initiatives.  

Tyler Jacks, Director of Koch Institute for Integrative Cancer Research at MIT.

Tom Lynch, President and Director of Fred Hutchinson Cancer Research Center.

Shiva Malek, Senior Director and Principal Scientist of Discovery Oncology at Genentech.

J.T. Poirier, a junior faculty from the Perlmutter Cancer Center at NYU Langone Health.



Related Videos

COVID-19

Nancy E. Davidson, MD, on Bringing Patients With Cancer Back to the Clinic During the COVID-19 Pandemic

Nancy E. Davidson, MD, of Fred Hutchinson Cancer Research Center, talks about a panel she moderated in which speakers discussed the importance of communicating with patients ...

COVID-19

Gabriella Pravettoni, PhD, on COVID-19 and Cancer: Psychological Effects on Patients and Oncologists

Gabriella Pravettoni, PhD, of the University of Milan, discusses the need for tailored psychological interventions to take care of oncologists, health-care workers, and patie...

COVID-19

Jessica Y. Islam, PhD, MPH, on COVID-19 Preventive Behaviors Among Cancer Survivors

Jessica Y. Islam, PhD, MPH, of the UNC Lineberger Comprehensive Cancer Center, discusses findings from the COVID-19 Impact Survey, which showed that cancer survivors are adhe...

COVID-19

Catherine H. Marshall, MD, MPH, on Promoting Recovery From COVID-19 Infection With Endocrine Therapy

Catherine H. Marshall, MD, MPH, of Johns Hopkins Hospital, discusses phase II trial results on bicalutamide, an oral antiandrogen used to treat prostate cancer. Bicalutamide ...

COVID-19

Karen E. Knudsen, MBA, PhD, on the Challenges of Using Telehealth in Cancer Care

Karen E. Knudsen, MBA, PhD, of the Sidney Kimmel Cancer Center at Jefferson Health, summarizes a panel she moderated on telehealth, which included discussion of usage in urba...

Advertisement

Advertisement



Advertisement